Pfizer Inc. (NEO: PFE)
Canada
· Delayed Price · Currency is CAD 12.22
+0.27 (2.26%)
Dec 20, 2024, 2:06 PM EST
Pfizer Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 29, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | 4,252 | 2,119 | 31,372 | 21,979 | 9,159 | 16,026 | Upgrade
|
| Depreciation & Amortization | 6,872 | 6,258 | 5,028 | 5,104 | 4,664 | 5,715 | Upgrade
|
| Asset Writedown & Restructuring Costs | 4,009 | 3,440 | 586 | 363 | 2,066 | 2,929 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | - | - | - | -8,254 | Upgrade
|
| Stock-Based Compensation | 821 | 525 | 872 | 1,182 | 755 | 687 | Upgrade
|
| Other Operating Activities | -7,171 | -1,485 | -2,946 | -8,943 | -5,797 | -6,185 | Upgrade
|
| Change in Accounts Receivable | 347 | 347 | 261 | -3,811 | -1,275 | -1,124 | Upgrade
|
| Change in Inventory | -1,169 | -1,169 | -591 | -1,125 | -778 | -1,071 | Upgrade
|
| Change in Accounts Payable | -300 | -300 | 1,191 | 1,242 | 355 | -341 | Upgrade
|
| Change in Other Net Operating Assets | 3,580 | -1,050 | -6,500 | 16,498 | 1,391 | -1,366 | Upgrade
|
| Operating Cash Flow | 11,263 | 8,700 | 29,267 | 32,580 | 14,403 | 12,588 | Upgrade
|
| Operating Cash Flow Growth | -6.47% | -70.27% | -10.17% | 126.20% | 14.42% | -20.47% | Upgrade
|
| Capital Expenditures | -3,036 | -3,907 | -3,236 | -2,711 | -2,226 | -2,046 | Upgrade
|
| Cash Acquisitions | -43,405 | -43,430 | -22,997 | - | - | -10,861 | Upgrade
|
| Investment in Securities | 39,717 | 15,239 | 6,682 | -19,517 | -1,672 | 9,304 | Upgrade
|
| Other Investing Activities | 3 | -180 | 3,768 | -318 | -373 | -342 | Upgrade
|
| Investing Cash Flow | -6,721 | -32,278 | -15,783 | -22,546 | -4,271 | -3,945 | Upgrade
|
| Short-Term Debt Issued | - | 7,686 | 3,891 | - | 12,352 | 19,006 | Upgrade
|
| Long-Term Debt Issued | - | 30,831 | - | 997 | 5,222 | 4,942 | Upgrade
|
| Total Debt Issued | 15,847 | 38,517 | 3,891 | 997 | 17,574 | 23,948 | Upgrade
|
| Short-Term Debt Repaid | - | -3 | -4,109 | -96 | -26,326 | -8,378 | Upgrade
|
| Long-Term Debt Repaid | - | -2,569 | -3,298 | -2,004 | -4,003 | -6,806 | Upgrade
|
| Total Debt Repaid | -12,511 | -2,572 | -7,407 | -2,100 | -30,329 | -15,184 | Upgrade
|
| Net Debt Issued (Repaid) | 3,336 | 35,945 | -3,516 | -1,103 | -12,755 | 8,764 | Upgrade
|
| Repurchase of Common Stock | - | - | -2,000 | - | - | -8,865 | Upgrade
|
| Common Dividends Paid | -9,447 | -9,247 | -8,983 | -8,729 | -8,440 | -8,043 | Upgrade
|
| Dividends Paid | -9,447 | -9,247 | -8,983 | -8,729 | -8,440 | -8,043 | Upgrade
|
| Other Financing Activities | -473 | -632 | -335 | 16 | 11,546 | -341 | Upgrade
|
| Financing Cash Flow | -6,584 | 26,066 | -14,834 | -9,816 | -9,649 | -8,485 | Upgrade
|
| Foreign Exchange Rate Adjustments | -38 | -40 | -165 | -59 | -8 | -32 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | -1 | - | - | - | - | -1 | Upgrade
|
| Net Cash Flow | -2,081 | 2,448 | -1,515 | 159 | 475 | 125 | Upgrade
|
| Free Cash Flow | 8,227 | 4,793 | 26,031 | 29,869 | 12,177 | 10,542 | Upgrade
|
| Free Cash Flow Growth | 0.60% | -81.59% | -12.85% | 145.29% | 15.51% | -23.85% | Upgrade
|
| Free Cash Flow Margin | 13.86% | 8.19% | 25.95% | 36.74% | 29.24% | 25.77% | Upgrade
|
| Free Cash Flow Per Share | 1.44 | 0.84 | 4.54 | 5.23 | 2.16 | 1.86 | Upgrade
|
| Cash Interest Paid | 2,895 | 2,215 | 1,442 | 1,467 | 1,641 | 1,587 | Upgrade
|
| Cash Income Tax Paid | 3,412 | 3,147 | 7,867 | 7,427 | 3,153 | 3,664 | Upgrade
|
| Levered Free Cash Flow | 11,421 | 1,024 | 24,957 | 30,940 | 10,761 | 14,192 | Upgrade
|
| Unlevered Free Cash Flow | 13,321 | 2,405 | 25,731 | 31,747 | 11,666 | 15,175 | Upgrade
|
| Change in Net Working Capital | -1,460 | 3,778 | 1,325 | -11,290 | -2,335 | -5,710 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.